Management of Low-Risk Gestational Trophoblastic Neoplasia in Indigent Women

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 10, 2003, Pages 780-784

  Schorge, John O ^a   Lea, Jayanthi S ^b   Farrar, Diana F ^b   King, Melanie R ^b   Coleman, Robert L ^b   Miller, David S ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Indigent care; Methotrexate; Trophoblastic neoplasms

Indexed keywords

DACTINOMYCIN; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOLLOW UP; HUMAN; LOWEST INCOME GROUP; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CHICAGO; DELIVERY OF HEALTH CARE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; MEDICAL RECORDS; METHOTREXATE; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME; UNCOMPENSATED CARE; WOMEN'S HEALTH;

EID: 0142151626     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. FIGO Oncology Committee Report. Int J Obstet Gynecol 2002;77:285-287
2. Hancock BW, Welch EM, Gillespie AM, et al: A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer 2000;00:318-322
3. Kohorn EI, Goldstein DP, Hancock BW, et al: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for Trophoblastic Neoplasia: Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynecol Cancer 2000;10:84-88
4. Kohorn EI: Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: A progress report. J Reprod Med 2002;47:445-450
5. Goldstein DP, Zanten-Przybysz IV, Bernstein MR, et al: Revised FIGO staging system for gestational trophoblastic tumors: Recommendations regarding therapy. J Reprod Med 1998;43:37-43
6. Li MC, Hertz R, Spencer DB: Effects of methotrexate therapy upon choriocarcinoma and chorioadenomas. Proc Soc Exp Biol Med 1956;93:361-366
7. Kohorn EI: Gestational trophoblastic neoplasia and evidence-based medicine. J Reprod Med 2002;47:427-432
8. Soper JT, Clarke-Pearson DL, Berchuck A, et al: 5-Day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994;54:76-79
9. Homesley JD, Blessing JA, Rettenmaier M, et al: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988;72:413-418
10. Berkowitz RS, Goldstein DP, Bernstein MR: Methotrexate infusion and folinic acid in the primary therapy of non-metastatic gestational trophoblastic tumors. Gynecol Oncol 1990;36:56-59
11. Kohorn EI: Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? Gynecol Oncol 2002;85:36-39
12. Massad LS, Abu-Rustum NR, Lee SS, et al: Poor compliance with postmolar surveillance and treatment protocols by indigent women. Obstet Gynecol 2000;96:940-944
13. Smith HO, Prairie BA, Padilla LA, et al: Incidence and survival rates for gestational trophoblastic disease (GTD) in the U.S.A.: A SEER (1973-1997) population-based study (abstr). Gynecol Oncol 2002;84:535
14. Garrett AP, Garner EO, Goldstein DP, et al: Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. J Reprod Med 2002;47:355-362
15. Wong L-C, Ngan HYS, Cheng DKL, et al: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 2000;183:1579-1582